2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline

C145H94Cl6N16O4Pt6S2 — CID 157090541

IUPAC2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline
SMILESCOC(=O)c1ccc2ccc3ccc(-c4[c-]c5ccccc5o4)nc3c2n1.CSc1c[c-]c(-c2cccc(-c3cccc(C(=O)Nc4ccccc4)n3)n2)cc1.Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].[c-]1c(-c2ccccc2)ccc2ccc3ccc(-c4nc5ccccc5s4)nc3c12.[c-]1cc(N(c2ccccc2)c2ccccc2)nc2ccc3ccc(-c4ccccn4)nc3c12.[c-]1cccc2c1-c1nc(-c3nc4ccccc4[nH]3)ccc1CC2.[c-]1ccccc1-c1ccc2ccc3ccc(-c4ccccc4)nc3c2n1
InChIInChI=1S/C29H19N4.C26H15N2S.C24H18N3OS.C24H15N2.C22H13N2O3.C20H14N3.6ClH.6Pt/c1-3-9-22(10-4-1)33(23-11-5-2-6-12-23)28-19-16-24-25(31-28)17-14-21-15-18-27(32-29(21)24)26-13-7-8-20-30-26;1-2-6-17(7-3-1)20-13-11-18-10-12-19-14-15-23(27-25(19)21(18)16-20)26-28-22-8-4-5-9-24(22)29-26;1-29-19-15-13-17(14-16-19)20-9-5-10-21(26-20)22-11-6-12-23(27-22)24(28)25-18-7-3-2-4-8-18;1-3-7-17(8-4-1)21-15-13-19-11-12-20-14-16-22(18-9-5-2-6-10-18)26-24(20)23(19)25-21;1-26-22(25)17-11-9-14-7-6-13-8-10-16(23-20(13)21(14)24-17)19-12-15-4-2-3-5-18(15)27-19;1-2-6-15-13(5-1)9-10-14-11-12-18(21-19(14)15)20-22-16-7-3-4-8-17(16)23-20;;;;;;;;;;;;/h1-15,17-20H;1-15H;2-13,15-16H,1H3,(H,25,28);1-9,11-16H;2-11H,1H3;1-5,7-8,11-12H,9-10H2,(H,22,23);6*1H;;;;;;/q6*-1;;;;;;;6*+2/p-6
InChIKeyKOBOAJKHGVSUBJ-UHFFFAOYSA-H
MW3571.77 g/mol
LogP38.84
Rot. Bonds16

About 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline

2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline (PubChem CID 157090541) has the molecular formula C145H94Cl6N16O4Pt6S2 and a molecular weight of 3571.77 g/mol. Its IUPAC name is 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline.

Molecular Properties

Compound Name2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline
PubChem CID157090541
Molecular FormulaC145H94Cl6N16O4Pt6S2
Molecular Weight3571.77 g/mol
Exact Mass3566.31
IUPAC Name2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline
SMILESCOC(=O)c1ccc2ccc3ccc(-c4[c-]c5ccccc5o4)nc3c2n1.CSc1c[c-]c(-c2cccc(-c3cccc(C(=O)Nc4ccccc4)n3)n2)cc1.Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].[c-]1c(-c2ccccc2)ccc2ccc3ccc(-c4nc5ccccc5s4)nc3c12.[c-]1cc(N(c2ccccc2)c2ccccc2)nc2ccc3ccc(-c4ccccn4)nc3c12.[c-]1cccc2c1-c1nc(-c3nc4ccccc4[nH]3)ccc1CC2.[c-]1ccccc1-c1ccc2ccc3ccc(-c4ccccc4)nc3c2n1
InChIInChI=1S/C29H19N4.C26H15N2S.C24H18N3OS.C24H15N2.C22H13N2O3.C20H14N3.6ClH.6Pt/c1-3-9-22(10-4-1)33(23-11-5-2-6-12-23)28-19-16-24-25(31-28)17-14-21-15-18-27(32-29(21)24)26-13-7-8-20-30-26;1-2-6-17(7-3-1)20-13-11-18-10-12-19-14-15-23(27-25(19)21(18)16-20)26-28-22-8-4-5-9-24(22)29-26;1-29-19-15-13-17(14-16-19)20-9-5-10-21(26-20)22-11-6-12-23(27-22)24(28)25-18-7-3-2-4-8-18;1-3-7-17(8-4-1)21-15-13-19-11-12-20-14-16-22(18-9-5-2-6-10-18)26-24(20)23(19)25-21;1-26-22(25)17-11-9-14-7-6-13-8-10-16(23-20(13)21(14)24-17)19-12-15-4-2-3-5-18(15)27-19;1-2-6-15-13(5-1)9-10-14-11-12-18(21-19(14)15)20-22-16-7-3-4-8-17(16)23-20;;;;;;;;;;;;/h1-15,17-20H;1-15H;2-13,15-16H,1H3,(H,25,28);1-9,11-16H;2-11H,1H3;1-5,7-8,11-12H,9-10H2,(H,22,23);6*1H;;;;;;/q6*-1;;;;;;;6*+2/p-6
InChIKeyKOBOAJKHGVSUBJ-UHFFFAOYSA-H
XLogP38.84
TPSA255.14 Ų
H-Bond Donors2
H-Bond Acceptors20
Rotatable Bonds16
Heavy Atoms179
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003571.77
LogP ≤ 538.84
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline?
The IUPAC name of 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline (CID 157090541) is 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline.
What is the SMILES notation for 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline?
The canonical SMILES for 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline is COC(=O)c1ccc2ccc3ccc(-c4[c-]c5ccccc5o4)nc3c2n1.CSc1c[c-]c(-c2cccc(-c3cccc(C(=O)Nc4ccccc4)n3)n2)cc1.Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].Cl[Pt+].[c-]1c(-c2ccccc2)ccc2ccc3ccc(-c4nc5ccccc5s4)nc3c12.[c-]1cc(N(c2ccccc2)c2ccccc2)nc2ccc3ccc(-c4ccccn4)nc3c12.[c-]1cccc2c1-c1nc(-c3nc4ccccc4[nH]3)ccc1CC2.[c-]1ccccc1-c1ccc2ccc3ccc(-c4ccccc4)nc3c2n1.
What is the InChIKey of 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline?
The InChIKey is KOBOAJKHGVSUBJ-UHFFFAOYSA-H. The full InChI is InChI=1S/C29H19N4.C26H15N2S.C24H18N3OS.C24H15N2.C22H13N2O3.C20H14N3.6ClH.6Pt/c1-3-9-22(10-4-1)33(23-11-5-2-6-12-23)28-19-16-24-25(31-28)17-14-21-15-18-27(32-29(21)24)26-13-7-8-20-30-26;1-2-6-17(7-3-1)20-13-11-18-10-12-19-14-15-23(27-25(19)21(18)16-20)26-28-22-8-4-5-9-24(22)29-26;1-29-19-15-13-17(14-16-19)20-9-5-10-21(26-20)22-11-6-12-23(27-22)24(28)25-18-7-3-2-4-8-18;1-3-7-17(8-4-1)21-15-13-19-11-12-20-14-16-22(18-9-5-2-6-10-18)26-24(20)23(19)25-21;1-26-22(25)17-11-9-14-7-6-13-8-10-16(23-20(13)21(14)24-17)19-12-15-4-2-3-5-18(15)27-19;1-2-6-15-13(5-1)9-10-14-11-12-18(21-19(14)15)20-22-16-7-3-4-8-17(16)23-20;;;;;;;;;;;;/h1-15,17-20H;1-15H;2-13,15-16H,1H3,(H,25,28);1-9,11-16H;2-11H,1H3;1-5,7-8,11-12H,9-10H2,(H,22,23);6*1H;;;;;;/q6*-1;;;;;;;6*+2/p-6.
What are the key properties of 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline?
2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline has a molecular weight of 3571.77 g/mol, XLogP of 38.84, 16 rotatable bonds, 2 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(1H-benzimidazol-2-yl)-6,10-dihydro-5H-benzo[h]quinolin-10-ide;hexakis(chloroplatinum(1+));N,N-diphenyl-2-pyridin-2-yl-10H-1,7-phenanthrolin-10-id-8-amine;methyl 9-(3H-1-benzofuran-3-id-2-yl)-1,10-phenanthroline-2-carboxylate;6-[6-(4-methylsulfanylbenzene-6-id-1-yl)-2-pyridinyl]-N-phenylpyridine-2-carboxamide;2-(9-phenyl-10H-benzo[h]quinolin-10-id-2-yl)-1,3-benzothiazole;9-phenyl-2-phenyl-1,10-phenanthroline is sourced from PubChem (CID 157090541), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).